Water-structuring technology with the molecular chaperone proteins: Indicated application of the α-crystallin domains and imidazole-containing peptidomimetics in cosmetic skin care systems or dermatological therapeutic drug carrier formulations

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 28, Issue 3, 2011, Pages 203-253

  Babizhayev, Mark A ^a,b   Nikolayev, Gennady M ^c   Nikolayeva, Juliana G ^c   Yegorov, Yegor E ^d  

^a Innovative Vision Products Inc   (Russian Federation)

^b MOSCOW HELMHOLTZ RESEARCH INSTITUTE OF EYE DISEASES   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Carcinine; Electron spin resonance (esr); High performance nuclear magnetic resonance (nmr); Imidazole containing peptidomimetics; L carnosine; Molecular chaperone proteins; N acetylcarnosine; Patented pharmaceutical and cosmetic formulations; Photoaging; Skin diseases; Transglycation and universal antioxidant activities; Water binding and structuring characteristics of proteins; crystallin domains

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA CRYSTALLIN; ANTIOXIDANT; CARCININE; CARNOSINE; CHAPERONE; COLLAGEN; DRUG CARRIER; FREE RADICAL; HEAT SHOCK PROTEIN; IMIDAZOLE DERIVATIVE; LINOLEIC ACID; LIPID HYDROPEROXIDE; LIPOSOME; MEMBRANE LIPID; N ACETYLCARNOSINE; PEPTIDOMIMETIC AGENT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AGED; AGING; ANTIOXIDANT ACTIVITY; ARTEMIA FRANCISCANA; ARTICLE; BATCH PROCESS; BIOTECHNOLOGY; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; COSMETIC SKIN CARE SYSTEM; CUTANEOUS PARAMETERS; DERMATOLOGY; DESICCATION; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY SKIN; ELECTRON SPIN RESONANCE; ELECTROPHORESIS; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; GLYCATION; GRAVIMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMIDITY; HYDRATION; HYDROPHILICITY; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LOW TEMPERATURE; MOISTURE; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PATENT; PHOTOAGING; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN INDUCTION; PROTEOMICS; REJUVENATION; SHRIMP; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARE; SKIN CELL; SKIN DEFECT; SKIN DISEASE; SKIN PROTECTION; SKIN REJUVENATION; SKIN SMOOTHING; ULTRAVIOLET IRRADIATION; WATER STRUCTURING TECHNOLOGY;

EID: 79958801912     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.v28.i3.10     Document Type: Article

References (144)

1. Egawa, M, Tagami, H. Comparison of the depth profi les of water and water-binding substances in the stratum corneum determined in vivo by Raman spectroscopy between the cheek and volar forearm skin: effects of age, seasonal changes and artifi cial forced hydration. Br J Dermatol. 2008 February 158(2):251-260.
2. Lindberg M, Forslind BO. The skin as a barrier. In: Loden M, Maibach HI, editors. Dry skin and moisturizers chemistry and function. B.O. pp.27-38.
3. Hipkiss AR. Error-protein metabolism and ageing. Biogerontology. 2009 Aug;10(4):523-529.
4. Babizhayev MA, Nikolayev GM, Nikolayeva JG, Yegorov YE. A survey and analysis of the role of molecular chaperone proteins and imidazole-containing dipeptide-based compounds as molecular escorts into the skin during stress, injury, water structuring and other types of cutaneous pathophysiology. Int J Cosmet Sci. 2011 Feb;33(1):1-16.
5. Gopaul R, Knaggs H, Langerveld A. Reducing skin stress response with willow bark-derived salicin. Cosmetics & Toiletries, July 2010.
6. Benesch JL, Aquilina JA, Baldwin AJ, Rekas A, Stengel F, Lindner RA, Basha E, Devlin GL, Horwitz J, Vierling E, Carver JA, Robinson CV. The quaternary organization and dynamics of the molecular chaperone HSP26 are thermally regulated. Chem Biol. 2010 Sep 24;17(9):1008-1017.
7. Stromer T, Fischer E, Richter K, Haslbeck M, Buchner J. Analysis of the regulation of the molecularchaperone Hsp26 by temperature-induced dissociation: the N-terminal domail is important for oligomer assembly and the binding of unfolding proteins. J Biol Chem. 2004 Mar 19;279(12): 11222-11228.
8. Haley DA, Bova MP, Huang QL, Mchaourab HS, Stewart PL. Small heat-shock protein structures reveal a continuum from symmetric to variable assemblies. J Mol Biol 2000, 298: 261-272.
9. Babizhayev MA, Nikolayev GM, Nikolayeva JG, Yegorov YE. Biologic activities of molecular chaperones and pharmacologic chaperone imidazole-containing dipeptide-based compounds: natural skin care help and the ultimate challenge. implication for adaptive responses in the skin. Am J Ther. 2010 Sep 21. [Epub ahead of print].
10. Babizhayev MA, Yegorov YE. Advanced drug delivery of N-acetylcarnosine (N-acetyl-beta-alanyl-L-histidine), carcinine (beta-alanylhistamine) and L-carnosine (beta-alanyl-L-histidine) in targeting peptide compounds as pharmacological chaperones for use in tissue engineering, human disease management and therapy: from in vitro to the clinic. Recent Pat Drug Deliv Formul. 2010 Nov;4(3): 198-230.
11. Chinnathambi S, Tomanek-Chalkley A, Bickenbach JR. HSP70 and EndoG modulate cell death by heat in human skin keratinocytes in vitro. Cells Tissues Organs. 2008;187(2):131-140.
12. Chen Y, Voegeli TS, Liu PP, Noble EG, Currie RW. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-infiammation targets. Infiamm Allergy Drug Targets. 2007 Jun;6(2):91-100.
13. Rattan SI, Fernandes RA, Demirovic D, Dymek B, Lima CF. Heat stress and hormetin-induced hormesis in human cells: effects on aging, wound healing, angiogenesis, and differentiation. Dose Response. 2009;7(1):90-103.
14. Wang Z, Inokuchi T, Nemoto TK, Uehara M, Baba TT. Antisense oligonucleotide against collagenspecific molecular chaperone 47-kDa heat shock protein suppresses scar formation in rat wounds. Plast Reconstr Surg. 2003 May; 111(6):1980-1987.
15. Obayashi K, Akamatsu H, Okano Y, Matsunage K, Masaki H. Exogenous nitric oxide enhances the synthesis of type I collagen and heat shock protein 47 by normal human dermal fi broblasts. J Dermatol Sci. 2006 Feb; 41(2): 121-126.
16. Ohashi S, Abe H, Takahashi T, Yamamoto Y, Takeuchi M, Arai H, et-al. Advanced glycation end products increase collagen-specifi c chaperone protein in mouse diabetic nephropathy. J Biol Chem. 2004 May 7; 279(19): 19816-1923.
17. Frydman J. Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu Rev Biochem. 2001;70:603-647.
18. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 2002;295:1852-1858.
19. Haslbeck M. SHsps and their role in the chaperone network. Cell Mol Life Sci. 2002;59: 1649-1657.
20. Craig EA. Eukaryotic chaperonins: Lubricating the folding of WD-repeat proteins. Curr Biol. 2003;13:R904-R905.
21. Mogk A, Bukau B. Molecular chaperones: Structure of a protein disaggregase. Curr Biol. 2004;14: R78-R80.
22. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, Kim J, Dillmann WH, Browne SE, Hall A, Voellmy R, Tsuboi Y, Dawson TM, Wolozin B, Hardy J, Hutton M. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet. 2004 Apr 1;13(7):703-714.
23. MacRae TH. Structure and function of small heat shock/α-crystallin proteins: established concepts and emerging ideas. Cell Mol Life Sci. 2000;57:899-913.
24. Scharf K-D, Siddique M, Vierling E. The expanding family of Arabidopsis thaliana small heat stress proteins and a new family of proteins containing α-crystallin domains (Acd proteins). Cell Stress Chaperones. 2001;6:225-237.
25. Narberhaus F. α-crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network. Microbiol Mol Biol Rev 2002;66:64-93.
26. Sun W, Van Montagu M, Verbruggen N. Small heat shock proteins and stress tolerance in plants. Biochim Biophys Acta. 2002;1577:1-9.
27. Horwitz J. Alpha-crystallin. Exp Eye Res. 2003;76:145-153.
28. Kaksanalamai P, Robb FT. Small heat shock proteins from extremophiles: a review. Extremophiles. 2004;8:1-11.
29. Taylor RP, Benjamin IJ. Small heat shock proteins: a new classifi cation scheme in mammals. J Mol Cell Cardiol. 2005;38:433-444.
30. Koteiche HA, Mchaourab HS. The determinants of the oligomeric structure in Hsp 16.5 are encoded in the α-crystallin domain. FEBS Lett. 2002;519:16-22.
31. Sun Y, Mansour M, Crack JA, Gass GL, MacRae TH. Oligomerization, chaperone activity, and nuclear localization of p26, a small heat shock protein from Artemia franciscana. J Biol Chem. 2004;279:39999-40006.
32. Hasan A, Yu J, Smith DL, Smith JB. Thermal stability of human α-crystallins sensed by amide hydrogen exchange. Prot Sci. 2004, 13: 332-341.
33. Thampi P, Abraham EC. Infiuence of the C-terminal residues on oligomerization of αA-crystallin. Biochemistry. 2003;42:11857-11863.
34. MacRae TH. Structure and function of small heat shock/alpha-crystallin proteins: established concepts and emerging ideas. Cell Mol Life Sci. 2000 Jun;57(6):899-913.
35. Bloemendal H, editor. Molecular and cellular biology of the eye lens. New York: John Wiley & Sons; 1981.
36. Wistow GJ, Piatigorsky J. Lens crystallins: the evolution and expression of proteins for a highly specialized tissue. Annu Rev Biochem. 1988;57:479-504.
37. Horwitz, J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10449-1053.
38. Jakob U, Gaestel M, Engel K, Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem. 1993 Jan 25;. 268(3):1517-1520.
39. Bhat SP, Nagineni CN. Alpha B subunit of lens-specifi c protein alpha-crystallin is present in other ocular and non-ocular tissues. Biochem Biophys Res Commun. 1989 Jan 16;158(1):319-325.
40. Dubin RA, Wawrousek EF, Piatigorsky J. Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol Cell Biol. 1989 Mar; 9(3):1083-1091.
41. Iwaki T, Kume-Iwaki A, Liem RK, Goldman JE. Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell. 1989 Apr 7;57(1):71-78.
42. Kato K, Shinohara H, Kurobe N, Goto S, Inaguma Y, Ohshima K. Immunoreactive alpha A crystalline in rat non-lenticular tissues detected with a sensitive immunoassay method. Biochim Biophys Acta. 1991 Oct. 25;1080(2):173-180.
43. Srinivasan AN, Nagineni CN, Bhat SP. Alpha A-crystallin is expressed in non-ocular tissues. J Biol Chem. 1992 Nov 15;267(32):23337-22341.
44. Klemenz R, Fröhli E, Steiger RH, Schäfer R, Aoyama A. Alpha B-crystallin is a small heat shock protein. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3652-3656.
45. Dasgupta S, Hohman TC, Carper D. Hypertonic stress induces alpha B-crystallin expression. Exp Eye Res. 1992 Mar;54(3):461-470.
46. Lowe J, Landon M, Pike I, Spendlove I, McDermott H, Mayer RJ. Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseases. Lancet. 1990 Aug. 25;336(8713):515-516.
47. Iwaki T, Wisniewski T, Iwaki A, Corbin E, Tomokane N, Tateishi J, Goldman JE. Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Pathol. 1992 Feb;140(2):345-356.
48. Chiesi M, Longoni S, Limbruno U. Cardiac alpha-crystallin. III. Involvement during heart ischemia. Mol Cell Biochem. 1990 Sep. 21;97(2):129-136.
49. Ingolia TD, Craig EA. Four small Drosophila heat shock proteins are related to each other and to mammalian alpha-crystallin. Proc Natl Acad Sci U S A. 1982 Apr;79(7):2360-2364.
50. de Jong WW, Leunissen JA, Voorter CE. Evolution of the alpha-crystallin/small heat-shock protein family. Mol Biol Evol. 1993 Jan;10(1):103-126.
51. Maiti M, Kono M, Chakrabarti B. Heat-induced changes in the conformation of alpha- and betacrystallins: unique thermal stability of alpha-crystallin. FEBS Lett. 1988 Aug 15;236(1):109-114.
52. Klemenz R, Fröhli E, Aoyama A, Hoffmann S, Simpson RJ, Moritz RL, Schäfer R. Alpha B crystalline accumulation is a specifi c response to Ha-ras and v-mos oncogene expression in mouse NIH 3T3 fi broblasts. Mol Cell Biol. 1991 Feb;11(2):803-812.
53. Aoyama A, Fröhli E, Schäfer R, Klemenz R. Alpha B-crystallin expression in mouse NIH 3T3 fi broblasts: glucocorticoid responsiveness and involvement in thermal protection. Mol Cell Biol. 1993 Mar;13(3):1824-1835.
54. Spector A, Chiesa R, Sredy J, Garner W. CAMP-dependent phosphorylation of bovine lens alphacrystallin. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4712-476.
55. Roquemore EP, Dell A, Morris HR, Panico M, Reason AJ, Savoy LA, Wistow GJ, Zigler JS Jr, Earles BJ, Hart GW. Vertebrate lens alpha-crystallins are modifi ed by O-linked N-acetylglucosamine. J Biol Chem. 1992 Jan 5;267(1):555-563.
56. Kato K, Shinohara H, Goto S, Inaguma Y, Morishita R, Asano T. Copurifi cation of small heat shock protein with alpha B crystallin from human skeletal muscle. J Biol Chem. 1992 Apr 15;267(11): 7718-7725.
57. Zantema A, Verlaan-De Vries M, Maasdam D, Bol S, van der Eb A. Heat shock protein. 27 and alpha B-crystallin can form a complex, which dissociates by heat shock. J Biol Chem. 1992 Jun. 25;267(18):12936-12941.
58. Merck KB, Groenen PJ, Voorter CE, de Haard-Hoekman WA, Horwitz J, Bloemendal H, de Jong WW. Structural and functional similarities of bovine alpha-crystallin and mouse small heat-shock protein. A family of chaperones. J Biol Chem. 1993 Jan 15;268(2):1046-1052.
59. Rao PV, Horwitz J, Zigler JS Jr. Alpha-crystallin, a molecular chaperone, forms a stable complex with carbonic anhydrase upon heat denaturation. Biochem Biophys Res Commun. 1993 Feb 15;190(3):786-793.
60. Boyle D, Gopalakrishnan S, Takemoto L. Localization of the chaperone binding site. Biochem Biophys Res Commun. 1993 May 14;192(3):1147-1154.
61. Ellis RJ, van der Vies SM. Molecular chaperones. Annu Rev Biochem. 1991;60:321-347.
62. Georgopoulos C. The emergence of the chaperone machines. Trends Biochem Sci. 1992 Aug;17(8):295-299.
63. Gething MJ, Sambrook J. Protein folding in the cell. Nature. 1992 Jan. 2;355(6355):33-45.
64. Hendrick JP, Hartl FU. Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem. 1993;62:349-384.
65. Landry SJ, Gierasch LM. The chaperonin GroEL binds a polypeptide in an alpha-helical conformation. Biochemistry. 1991 Jul 30;30(30):7359-7362.
66. Landry SJ, Jordan R, McMacken R, Gierasch LM. Different conformations for the same polypeptide bound to chaperones DnaK and GroEL. Nature. 1992 Jan 30;355(6359):455-457.
67. Schmidt M, Buchner J. Interaction of GroE with an all-beta-protein. J Biol Chem. 1992 Aug. 25;267(24):16829-16833.
68. Martin J, Langer T, Boteva R, Schramel A, Horwich AL, Hartl FU. Chaperonin-mediated protein folding at the surface of groEL through a 'molten globule'-like intermediate. Nature. 1991 Jul 4;352(6330):36-42.
69. Tartaglia GG, Dobson CM, Hartl FU, Vendruscolo M. Physicochemical determinants of chaperone requirements. J Mol Biol. 2010 Jul 16;400(3):579-588.
70. Ranson NA, White HE, Saibil HR. Chaperonins. Biochem J. 1998 Jul 15;333(Pt 2):233-242.
71. Csermely P. Chaperone-percolator model: a possible molecular mechanism of Anfi nsen-cage-type chaperones. Bioessays. 1999 Nov;21(11):959-965.
72. Chan HS, Bromberg S, Dill KA. Models of cooperativity in protein folding. Philos Trans R Soc Lond B Biol Sci. 1995 Apr. 29;348(1323):61-70.
73. Hartl FU. Molecular chaperones in cellular protein folding. Nature. 1996 Jun 13;381(6583):571-579.
74. Trouba KJ, Hamadeh HK, Amin RP, Germolec DR. Oxidative stress and its role in skin disease. Antioxid Redox Signal. 2002 Aug;4(4):665-673.
75. Severin S.E. Problems concerned with the biological activity of naturally occurring imidazole compounds. Proceedings of Plen. Sess. Seventh International Biochemical Congress 1964, NY, pp.45-61.
76. Boldyrev AA, Severin SE. The histidine-containing dipeptides, carnosine and anserine: distribution, properties and biological signifi cance. Adv Enzyme Regul. 1990;30:175-194.
77. Aldini G, Facino RM, Beretta G, Carini M. Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. Biofactors. 2005;24(1-4):77-87.
78. Aldini G, Orioli M, Carini M, Maffei Facino R. Profi ling histidine-containing dipep-tides in rat tissues by liquid chromatography/electrospray ionization tandem mass spectrometry. J Mass Spectrom. 2004 Dec;39(12):1417-1428.
79. Orioli M, Aldini G, Beretta G, Facino RM, Carini M. LC-ESI-MS/MS determination of 4-hydroxytrans- 2-nonenal Michael adducts with cysteine and histidine-containing peptides as early markers of oxidative stress in excitable tissues. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Nov 15;827(1):109-118.
80. Reddy VP, Garrett MR, Perry G, Smith MA. Carnosine: a versatile antioxidant and antiglycating agent. Sci Aging Knowledge Environ. 2005 May 4;2005(18):pe 12.
81. Rashid I, van Reyk DM, Davies MJ. Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro. FEBS Lett. 2007;581(5):1067-1070.
82. Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Kurysheva NI, Zhukotskii AV, Goldman IM. N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Peptides. 2001; 22:979-994.
83. Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Doroshenko VS, Zhukotskii AV, Goldman IM. Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs R D. 2002;3(2): 87-103.
84. Babizhayev MA, Deyev AI, Yermakova VN, Remenschikov VV, Bours J. Revival of the lens transparency with N-acetylcarnosine. Current Drug Therapy. 2006;1:91-116.
85. Babizhayev MA, Deyev AI, Yermakova VN, Brikman IV, Bours J. Lipid peroxidation and cataracts: Nacetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes. Drugs R D. 2004;5(3):125-139.
86. Babizhayev, M.A.,. 2004. Method for topical treatment of eye disease and composition and device for said treatment. PCT Patent Application. International Publication Number WO. 2004/028536 A1. International Publication Date: 8 April. 2004.
87. Babizhayev MA. Ophthalmic pharmacology of N-acetylcarnosine lubricant eye drops. J Pharmacol Toxicol. 2006;1(3):201-233.
88. Babizhayev MA. Rejuvenation of visual functions in older adult drivers and drivers with cataract during a short-term administration of N-acetylcarnosine lubricant eye drops. Rejuvenation Research. 2004;7:186-198.
89. Babizhayev MA, Yermakova VN, Deyev AI, Seguin MC. Imidazole-containing peptidomimetic NACA as a potent drug for the medicinal treatment of age-related cataract in humans. Journal of Anti-Aging Medicine. 2000;3:43-62.
90. Arnould JM, Frentz R. Presence, isolation and chemical structure of a substance characteristic of cardiac tissue in Carcinus maenas (L.): beta-alanylhistamine. Comp Biochem Physiol C. 1975 Jan 1;50(1):59-66.
91. Brotman DN, Flancbaum L, Fitzpatrick JC, Fisher H. Presence of carcinine (β-alanylhistamine) in mammalian tissues. FASEB J. 1989;3:1028.
92. Brotman DN, Flancbaum L, Kang YH, Merrill GF, Fisher H. Positive inotropic effects of carcinine in the isolated, perfused guinea pig heart. Crit Care Med. 1990;18:317-321.
93. Babizhayev MA. Biological activities of the natural imidazole-containing peptidomimetics nacetylcarnosine, carcinine and L-carnosine in ophthalmic and skin care products. Life Sci. 2006 Apr 11;78(20):2343-2357.
94. Babizhayev MA, Seguin MC, Gueyne J, Evstigneeva RP, Ageyeva EA, Zheltukhina GA. Lcarnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities. Biochem J. 1994 Dec 1;304 (Pt 2):509-16.
95. Yan H, Harding JJ. Carnosine inhibits modifi cations and decreased molecular chaperone activity of lens alpha-crystallin induced by ribose and fructose 6-phosphate. Mol Vis. 2006 Mar. 27;12: 205-214.
96. Babizhayev MA, Nikolayev GN, Goryachev SN, Bours J. NMR spin-echo studies of hydration properties of the molecular chaperone alpha-crystallin in the bovine lens. Biochim Biophys Acta. 2002 Jul. 29;1598(1/2):46-54.
97. Farrar TC, Becker ED. Pulse and Fourier transform NMR: introduction to theory and methods. New York: Academic Press; 1971.
98. Stewart, J.J.P., 1989. MOPAC. F.J. Seiler Research Laboratory. Air Force Academy, Boulder, pp. 80840.
99. Stewart, J.J. MOPAC. Ver.6, QCPE Bull.,1989. 9,10. Revised as Ver. 6.01 by T. Hirano, University of Tokyo, for HITAC and UNIX machines (JCPE Newsletter., 1989. 1,10).
100. Bolland JL, Koch HP. The course of autooxidation reactions in polyisoprenes and allied compounds. Part IX. The primary thermal oxidation pproducts of ethyl linoleate. J Chem Soc. 1945;7:445-447.
101. Chio KS, Tappel AL. Synthesis and characterization of the fiuorescent products derived from malonaldehyde and amino acids. Biochemistry. 1969 Jul;8(7):2821-2826.
102. Babizhayev MA. Antioxidant activity of l-carnosine, a natural histidine-containing dipeptide in crystalline lens. Biochim Biophys Acta. 1989;1004:363-371.
103. Babizhayev MA, Costa EB. Lipid peroxide and reactive oxygen species generating systems of the crystalline lens. Biochim Biophys Acta. 1994 Feb 22;1225(3):326-337.
104. Iacazio G, Langrand G, Baratti J, Buono G, Triantaphylides CJ. Preparative, enzymatic synthesis of linoleic acid (13S)-hydroperoxide using soybean lipoxygenase-1. Organic Chemistry. 1993;55:1690.
105. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680-685.
106. Sammons DW, Adams LD, Nishizawa EE. Ultra sensitive silver based color staining of polypeptides in polyacrylamide gels. Electrophoresis. 1981;2:135.
107. Guiotto A, Ruzza P, Babizhayev MA, Calderan A. Malondialdehyde scavenging and aldose-derived Schiff bases' transglycation properties of synthetic histidyl-hydrazide carnosine analogs. Bioorg Med Chem. 2007 Sep 15;15(18):6158-6163.
108. Szwergold BS. Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases. Biochem Biophys Res Commun. 2005 Oct 14;336(1):36-41.
109. Nikolayeva YG, Nikolayev GM, Timofeev KN, Frolov VA, Syroyeshkin AV. Study of the water state in the forms of Artemia salina L. at calm. Annals of Russian University of Peoples' Friendship (medicine series). 2007;1:5-9.
110. Sruvastava PK, Menore A, Busu S, Binder RJ. Heat Shock proteins come of age: Primitive functions acquire new roles in an adaptive world. Immunity; 1998;8:657-665.
111. Aldini G, Carini M, Beretta G, Bradamante S, Facino RM. Carnosine is a quencher of 4-hydroxy- nonenal: through what mechanism of reaction? Biochem Biophys Res Commun. 2002 Nov 15;298(5):699-706.
112. Pegova A, Abe H, Boldyrev A. Hydrolysis of carnosine and related compounds by mammalian carnosinases. Comp Biochem Physiol B Biochem Mol Biol. 2000 Dec;127(4):443-446.
113. Miyachi Y, Imamura S, Niwa Y. Decreased skin superoxide dismutase activity by a single exposure of ultraviolet radiation is reduced by liposomal superoxide dismutase pretreatment. J Invest Dermatol. 1987 Jul;89(1):111-112.
114. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab. 2000 May;26(3):163-176.
115. Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med. 1996 Oct;28(5):419-426.
116. Baynes JW. The role of AGEs in aging: causation or correlation. Exp Gerontol. 2001 Sep;36(9): 1527-1537.
117. Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol. 2006 Feb;126(2):291-299.
118. Babizhayev MA, Guiotto A, Kasus-Jacobi A. N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications. J Drug Target. 2009 Jan;17(1):36-63.
119. Stitt AW, Curtis TM. Advanced glycation and retinal pathology during diabetes. Pharmacol Rep. 2005;57(Suppl):156-168.
120. Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, Hsu DK, Liu FT, Thorpe SR, Gardiner TA. Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes. 2005 Mar;54(3):785-794.
121. Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production. Biochem J. 1993 Apr 15;291(Pt 2):529-535.
122. Neglia CI, Cohen HJ, Garber AR, Thorpe SR, Baynes JW. Characterization of glycated proteins by 13C-NMR spectroscopy. Identifi cation of specifi c sites of protein modifi cation by glucose. J Biol Chem. 1985 May 10;260(9):5406-5410.
123. Mossine VV, Glinsky GV, Feather MS. The preparation and characterization of some Amadori compounds(1-amino-1-deoxy-D-fructose derivatives) derived from a series of aliphatic omega-amino acids. Carbohydr Res. 1994 Sep 15;262(2):257-270.
124. Babizhayev, M.A. and Meguro, K.,. 2004. COMBINED USE OF CARNOSINASE INHIBITOR WITH L-CARNOSINES AND COMPOSITION. WO. 2004/064866 PCT/JP2004/000351. Filed. 20 January. 2003 (20.01.2003).
125. Babizhayev MA, Seguin M-C. Coupling product obtained from histamine and an amino acid. US Patent Number 5,792,784. Date of Patent August 11, 1998.
126. Conner JR, Beisswenger PJ, Szwergold BS. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein. Ann N Y Acad Sci. 2005 Jun;1043:824-836.
127. Gabuda SP. Bound water: facts and hypothesis. In: Yakovlev II, editor. Bound Water: facts and hypothesis [in Russian]. Nauka, Novosibirsk. 2005. p. 157.
128. Augusteyn RC, Koretz JF. A possible structure for alpha-crystallin. FEBS Lett. 1987 Sep. 28;222(1): 1-5.
129. Carver JA, Aquilina JA, Truscott RJ. A possible chaperone-like quaternary structure for alpha-crystallin. Exp Eye Res. 1994 Aug;59(2):231-234.
130. Morris SD. Heat shock proteins and the skin. Clin Exp Dermatol. 2002 May;27(3):220-224.
131. Sun Y, Bojikova-Fournier S, MacRae TH. Structural and functional roles for beta-strand 7 in the alpha-crystallin domain of p26, a polydisperse small heat shock protein from Artemia franciscana. FEBS J. 2006 Mar;273(5):1020-1034.
132. Babizhayev MA, Nikolayev GM, Goryachev SN, Bours J, Martin R. Hydration properties of the molecular chaperone alpha-crystallin in the bovine lens. Biochemistry (Mosc). 2003 Oct;68(10): 1145-1155.
133. Spector A, Rothschild C. The effect of calcium upon the reaggregation of bovine alpha crystallin. Invest Ophthalmol. 1973 Mar;12(3):225-231.
134. Biswas A, Das KP. Zn2+ enhances the molecular chaperone function and stability of alpha-crystallin. Biochemistry. 2008 Jan 15;47(2):804-816.
135. Ahmad MF, Singh D, Taiyab A, Ramakrishna T, Raman B, Rao CM. Selective Cu2+ binding, redox silencing, and cytoprotective effects of the small heat shock proteins alphaA- and alphaB-crystallin. J Mol Biol. 2008 Oct 10;382(3):812-824.
136. Calabrese V, Scapagnini G, Catalano C, Bates TE, Geraci D, Pennisi G, Giuffrida Stella AM. Regulation of heat shock protein synthesis in human skin fi broblasts in response to oxidative stress: role of vitamin E. Int J Tissue React. 2001;23(4):127-135.
137. Vanhooren V, Liu XE, Desmyter L, Fan YD, Vanwalleghem L, Van Molle W, Dewaele S, Praet M, Contreras R, Libert C, Chen C. Over-expression of heat shock protein 70 in mice is associated with growth retardation, tumor formation, and early death. Rejuvenation Res. 2008 Dec;11(6):1013-1020.
138. Kayani AC, Close GL, Broome CS, Jackson MJ, McArdle A. Enhanced recovery from contraction-induced damage in skeletal muscles of old mice following treatment with the heat shock protein inducer 17-(allylamino)-17-demethoxygeldanamycin. Rejuvenation Res. 2008 Dec;11(6):1021-1030.
139. Baguet A, Reyngoudt H, Pottier A, Everaert I, Callens S, Achten E, Derave W. Carnosine loading and washout in human skeletal muscles. J Appl Physiol. 2009 Mar;106(3):837-842.
140. Peñafi el R, Ruzafa C, Monserrat F, Cremades A. Gender-related differences in carnosine, anserine and lysine content of murine skeletal muscle. Amino Acids. 2004 Feb;26(1):53-58.
141. Hipkiss AR, Brownson C, Bertani MF, Ruiz E, Ferro A. Reaction of carnosine with aged proteins: another protective process? Ann N Y Acad Sci. 2002 Apr;959:285-294.
142. Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res. 2008 Dec;33(12):2444-2471.
143. Yamagishi SI, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev. 2005;1:93-106.
144. Hobart LJ, Seibel I, Yeargans GS, Seidler NW. Anti-cross-linking properties of carnosine: Signifi cance of histidine. Life Sci. 2004 Jul 30;75(11):1379-1389.